Evidence map›Paper›PMID 33644227›Full record

ArticleBioMed research international2021

Corrigendum to "Drug Delivery Nanoparticles in Skin Cancers".

Chiara Dianzani, Gian Paolo Zara, Giovanni Maina, Piergiorgio Pettazzoni, Stefania Pizzimenti, Federica Rossi, Casimiro Luca Gigliotti, Eric Stefano Ciamporcero, Martina Daga, Giuseppina Barrera

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Chiara DianzaniDepartment of Drug Science and Technology, University of Turin, 10125 Turin, Italy.ORCID https://orcid.org/0000-0002-2246-3183
Gian Paolo ZaraDepartment of Drug Science and Technology, University of Turin, 10125 Turin, Italy.ORCID https://orcid.org/0000-0002-0058-8743
Giovanni MainaDepartment of Clinical and Biological Sciences, University of Turin, 10125 Turin, Italy.ORCID https://orcid.org/0000-0002-6908-9790
Piergiorgio PettazzoniDepartment of Genomic Medicine, University of Texas-MD Anderson Cancer Center, TX 77030 Houston, USA.ORCID https://orcid.org/0000-0001-5513-4493
Stefania PizzimentiDepartment of Clinical and Biological Sciences, University of Turin, 10125 Turin, Italy.ORCID https://orcid.org/0000-0001-6937-8632
Federica RossiDepartment of Public and Pediatric Health Sciences, University of Turin, 10126 Turin, Italy.
Casimiro Luca GigliottiDepartment of Health Sciences, University of Eastern Piedmont "Amedeo Avogadro", 28100 Novara, Italy.ORCID https://orcid.org/0000-0002-3127-5686
Eric Stefano CiamporceroDepartment of Clinical and Biological Sciences, University of Turin, 10125 Turin, Italy.ORCID https://orcid.org/0000-0002-3856-6435
Martina DagaDepartment of Clinical and Biological Sciences, University of Turin, 10125 Turin, Italy.ORCID https://orcid.org/0000-0001-7377-7847
Giuseppina BarreraDepartment of Clinical and Biological Sciences, University of Turin, 10125 Turin, Italy.ORCID https://orcid.org/0000-0002-8587-4166

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1155/2014/895986.].

Identifiers

PMID33644227
PMCPMC7902146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.